{"id":"F2013L00014","name":"Therapeutic Goods (Listing) Notice 2012 (No. 4)","slug":"therapeutic-goods-listing-notice-2012-no-4","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":126816,"registerId":"commonwealth-F2013L00014-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2012 (No. 4)","content":"Therapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2012 (No. 4)\n\nI, JILL JEPSON, Acting National Manager of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:\n\n-   preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘calcified Lithothamnion tophiforme’ as a therapeutically active ingredient, subject to the following condition:\n    -   the preparations are for oral use only.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.\n\nDated this 14th day of December 2012\n\n(Signed by)\n\nJill Jepson\n\nDelegate of the Minister for Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1229},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"The instrument operates exactly within the scope intended by section 9A(5) of the Therapeutic Goods Act 1989, which specifically provides for interim listing of therapeutic goods pending regulatory amendment. The temporary nature and specific ingredient focus align with the delegated authority."},"complexity_factors":["Single operative provision covering one specific ingredient","Only one condition (oral use restriction)","No interpretation section or defined terms","Minimal legislative cross-referencing (only authorising provision and Regulations)"],"plain_english_summary":"This notice temporarily allows dietary supplements and natural medicines containing **calcified Lithothamnion tophiforme** (a calcified red algae, also known as red seaweed) to be sold in Australia.\n\n**What it does:**\n- Adds this specific algae to the Australian Register of Therapeutic Goods (ARTG) as a \"listed\" medicine (a lower-risk category for complementary medicines)\n- Only applies to products where this algae is an active (therapeutic) ingredient\n- **Restriction:** Products must be for **oral use only** (tablets, capsules, powders taken by mouth—not creams or injections)\n\n**Why it exists:**\nThis is a temporary \"bridge\" measure. Instead of waiting months or years for formal regulations to be amended, this notice immediately permits these products to be legally supplied. It automatically expires once the Therapeutic Goods Regulations 1990 are formally updated to include this ingredient."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2012-no-4","history":"/api/acts/therapeutic-goods-listing-notice-2012-no-4/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2012-no-4/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2012-no-4/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2012-no-4/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2012-no-4/documents"}}